Etiology of cardiovascular disease in patients with schizophrenia: current perspectives

Overview of attention for article published in Neuropsychiatric Disease and Treatment, October 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 7 X users
facebook: 2 Facebook pages

googleplus: 1 Google+ user

Citations

dimensions_citation: 51 Dimensions

Readers on

mendeley: 169 Mendeley

Summary X Facebook Google+ Dimensions citations

So far, Dimensions has found 51 publications that cite this research output.

51

The most recent citing publications are shown below. View all 51 publications that cite this research output on Dimensions.

Effects of atypical antipsychotics on serum asprosin level and other metabolic parameters in patients with schizophrenia

Article in Human Psychopharmacology Clinical and Experimental (June 2024)

Psychotropic medications and mortality from cardiovascular disease and suicide for individuals with depression in Taiwan

Article in Asian Journal of Psychiatry (May 2024)

Prevalence of metabolic syndrome and its associated factors in first‐treatment drug‐naïve schizophrenia patients: A large‐scale cross‐sectional study

Article in Early Intervention in Psychiatry (May 2024)